InsidersTradesSigma
Follow the Orexo AB share price and the full insider trade history of the company, a listed issuer based in Finland. Shares are quoted on FI FI, under the authority of FIN-FSA. Operating in the Health Care sector, Orexo AB has logged 0 insider filings. Market capitalisation: €546.6m. All data is accessible without an account.
Analysts rate Orexo AB Strong Buy (bullish), based on 1 analysts. Average price target: SEK 26.50.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
0 of 0 declarations
Orexo AB is a pharmaceutical company focused on developing treatments for addiction and pain disorders. It is listed on the Stockholm Stock Exchange (XSTO).